Table 5.
Parameter | Dpi | SEM | P-value | |||||
---|---|---|---|---|---|---|---|---|
5 | 20 | |||||||
Control | PEDV | Control | PEDV | trt | dpi | trt × dpi | ||
Glucagon, pg/mL | 132 | 135 | 205 | 148 | 25.517 | 0.304 | 0.104 | 0.252 |
Glucose, mg/dL | 96b | 83b | 105b | 130a | 8.002 | 0.463 | 0.002 | 0.024 |
Insulin, ng/mL | 0.09b | 0.18b | 0.17b | 0.51a | 0.044 | <0.001 | <0.001 | 0.010 |
Insulin:glucose2 | 2.60c | 7.29b | 4.57bc | 11.18a | 1.203 | <0.001 | 0.021 | 0.433 |
NEFA, mEq/L | 0.16a | 0.20a | 0.09b | 0.09b | 0.023 | 0.534 | 0.005 | 0.473 |
BUN, mg/dL | 6.78a | 5.68ab | 6.46ab | 4.81b | 0.599 | 0.030 | 0.328 | 0.643 |
Haptoglobin, µg/mL | 280y | 460x | 240y | 224y | 57.350 | 0.162 | 0.023 | 0.100 |
trt, treatment.
1Estimates are represented by eight observations per treatment per time.
2Units in mol:mol/L × 10–9.
a,bMeans without a common superscript differ (P ≤ 0.05); x,yMeans without a common superscript differ (P < 0.10).